H2020Individual fellowship2020–2022

DC Metabolism · Metabolic Regulation of Conventional Dendritic Cell Development and Function

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2020-07-01 → 2022-06-30
EU contribution
€212,934
Participants
1
Scheme
MSCA-IF

Lines connect the coordinator with its partners.

Results in brief

Metabolic Regulation of Conventional Dendritic Cell Development and Function

Dendritic cells (DCs) are key sentinel immune cells that alert the body to the presence of damage or infection, and arm T-lymphocytes to expand and eliminate aberrant or infected cells. Despite their importance in immunity, the mechanisms that govern their development and specific functions are not fully understood. Conventional DCs can be subdivided into type 1 (cDC1) and 2 (cDC2) subsets, which both descend from a common precursor under the shared influence of the growth factor cytokine Flt3L. The signals that differentiate cDC1 from cDC2 during development remain unknown. Apart from development, cDC1 and cDC2 also have specialized roles in immune responses. cDC1 are important for arming CD8+ T cells by processing and presenting proteins derived from cancer or infected cells through a process termed cross-presentation, whereas cDC2 help mediate immunity to parasites and extracellular bacteria. The importance of cDC1 in controlling immune responses against cancer is established by numerous studies demonstrating that a lack of cDC1 in mice impairs their rejection of tumours and responses to immune checkpoint blockade and adoptive T cell therapies. However, the precise mechanisms underlying the ability of cDC1 to cross-present are unclear. Imbedded in immune cell physiology are metabolic pathways and metabolites that not only serve to provide energy and breakdown or produce nutrients for growth and survival, but also to instruct their development and function. For example, failure to engage specific metabolic pathways has been found to impair the development of memory T cells and the activation of macrophages, another type of sentinel immune cell. This project aims at delineating the role and importance of metabolic regulation in DC basic biology by answering two main questions: do distinct metabolic programs dictate cDC1 versus cDC2 specification, and what are the metabolic pathways or nutrients required for cDC1-dependent cross-presentation? Understanding the role metabolism plays in directing DC physiology will identify novel mechanisms of immune cell control with implications for antiviral and anticancer immunity. The conclusions of the action are thus far: the metabolic profiles of cDC1 and cDC2 were assessed and a specific isoform of hexokinase, a protein essential to the metabolism of sugar, was found to be expressed primarily by cDC1. Preliminary data using novel reagents suggests that this isoform may be critical to cDC1 differentiation and survival.

Data: CORDIS, © European Union

Project objective

Dendritic cells (DCs) play critical roles in directing innate and adaptive immune responses against infections and cancer. Understanding the mechanisms that control DC development and function may reveal new ways to alter the course of complex human diseases such as cancer. Despite their importance in immunity, some open questions remain in regards to DC basic biology. Two of these questions, in particular, are the subject of this application: 1) DCs are a heterogenous population, which can be subdivided into conventional DC type 1 (cDC1) and 2 (cDC2) subsets. Although their development depends on distinct transcriptional programs, cDC1 and cDC2 descend from a common precursor under the influence of the same growth factor cytokine. What determines cDC1/2 differentiation? 2) Various loss-of-function studies demonstrate that cDC1 are key antigen-presenting cells for initiating CD8+ T cell responses to tumours and some viruses. This primarily relies on a process termed cross-presentation. How is cross-presentation regulated in cDC1? Recent studies indicate that profound changes in cellular metabolism are coupled to immune cell function and may fundamentally underpin cell-fate decisions. Based on previous observations and our own preliminary data, we hypothesise that glycolysis programs cDC1 development and activation, whereas fatty acid metabolism controls the ability of the same cells to cross-present antigens to CD8+ T cells. We propose to define the metabolic programs that drive DC formation and that underlie cDC1 and cDC2 identity and complement this approach with loss and gain-of-function experiments that will allow specific testing of our hypotheses. Globally, these studies will identify novel mechanisms of immune cell control with implications for antiviral and anticancer immunity.

Original text from CORDIS.

Participants

  • THE FRANCIS CRICK INSTITUTE LIMITED · LondonCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union